Long-term estrogen therapy changes microbial activity in gut: study

          Source: Xinhua| 2018-06-20 05:16:06|Editor: yan
          Video PlayerClose

          CHICAGO, June 19 (Xinhua) -- Long-term therapy with estrogen and bazedoxifene alters the microbial composition and activity in the gut, affecting how estrogen is metabolized, a study in mice conducted by the University of Illinois (UI) found.

          The UI researchers divided 40 female mice into five treatment groups, which were treated with various estrogens, administered alone or in combination with the estrogen-receptor drug bazedoxifene. The mice were fed a high-fat diet and their ovaries were removed at 10 weeks of age to replicate the estrogen-deficient environment associated with menopause.

          After six weeks of treatment, the researchers extracted DNA samples from the mice to examine gene transcription. They also examined the microbiota in the mice's cecums and in their fecal samples to assess the microbial diversity and activity in their digestive tracts.

          "We observed that both levels of fecal GUS activity and glucuronic acid, a byproduct of estrogen metabolism, decreased after the mice were treated with conjugated estrogens and bazedoxifene," said UI food science and human nutrition professor Zeynep Madak-Erdogan. "This supported our hypothesis that estrogen supplementation affects the gut microbiome composition and estrogen metabolism."

          "While the overall diversity of microbiota was not changed significantly, we found that the activities of several bacteria taxa were altered by the estrogen therapy," Madak-Erdogan said.

          The levels of several bacteria associated with GUS activity in the gut decreased, including levels of akkermansia, a family of bacteria believed to have anti-inflammatory properties in humans.

          Fecal levels of akkermansia were significantly lower in mice treated with the estrogen-bazedoxifene combination compared with their peers in the control group.

          However, mice with higher levels of akkermansia in their fecal biome gained more weight, had larger livers and more estrogen metabolites in their systems, the researchers found.

          In examining the abundance of common bacterial families in the fecal microbiota, the researchers found higher levels of several microbes, including lactobacillus and streptococcus. Lactobacillus was shown to be associated with GUS activity in previous studies by other researchers while GUS was identified in a subspecies of streptococcus.

          The GUS bacteria also interacted with two metabolites of the cancer-inhibiting drug tamoxifen, an important finding because lower serum concentrations of the drug have been linked with poorer outcomes in breast cancer patients, according to the study.

          "Our findings indicate that clinicians might be able to manipulate the gut biome through probiotics to change the half-life and properties of estrogens so that long-term users obtain the therapeutic benefits of estrogen-replacement therapy without increasing their risks of reproductive cancers," said Madak-Erdogan.

          The findings have been published in the journal Scientific Reports.

          TOP STORIES
          EDITOR’S CHOICE
          MOST VIEWED
          EXPLORE XINHUANET
          010020070750000000000000011105521372659801
          无码人妻一区二区三区四区av_亚洲精品911在线永久观看_精品一区二区国产在线观看_日韩不卡一区二区视频在线

                  中文字幕在线视频观看网站 | 又黄又爽又无遮挡国产 | 亚洲中文字幕久久 | 在线精品亚洲一区二区三区动态图 | 最精彩色站在线播放 | 亚洲国产一级精品视频二区 |